Anti-Cd20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2013.00502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search